Mettler-Toledo International (NYSE:MTD) Given New $1,400.00 Price Target at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its price target raised by equities research analysts at Wells Fargo & Company from $1,350.00 to $1,400.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s target price would suggest a potential upside of 1.94% from the company’s previous close.

Several other brokerages also recently weighed in on MTD. Wolfe Research started coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating for the company. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their target price for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Robert W. Baird boosted their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday. Stifel Nicolaus dropped their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Finally, Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $1,364.88.

Mettler-Toledo International Trading Up 1.2 %

Shares of NYSE:MTD opened at $1,373.31 on Monday. The stock has a fifty day simple moving average of $1,278.92 and a two-hundred day simple moving average of $1,342.95. Mettler-Toledo International has a 12-month low of $1,133.46 and a 12-month high of $1,546.93. The stock has a market capitalization of $28.98 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 4.80 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 564.51% and a net margin of 22.29%. As a group, equities research analysts predict that Mettler-Toledo International will post 41.94 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MTD. Blue Trust Inc. lifted its position in shares of Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 17 shares in the last quarter. Ashton Thomas Securities LLC purchased a new position in Mettler-Toledo International in the 3rd quarter worth approximately $37,000. SBI Securities Co. Ltd. purchased a new position in Mettler-Toledo International in the 4th quarter worth approximately $33,000. Raleigh Capital Management Inc. boosted its stake in Mettler-Toledo International by 272.7% in the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 30 shares during the period. Finally, Whipplewood Advisors LLC purchased a new stake in Mettler-Toledo International during the 4th quarter valued at approximately $54,000. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.